The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
Intramolecular trapping of a cyclopropylidenamine during the favorskii rearrangement of α-chloroketimines
作者:Norbert De Kimpe、Elena Stanoeva、Niceas Schamp
DOI:10.1016/s0040-4039(00)80158-6
日期:——
Cyclopropylidenamines have been trapped for the first time in an intramolecular way during the Favorskiirearrangement of suitably functionalized α-chloroketimines.
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
Synthesis of oxygen-containing heterocyclic compounds via α-chloro-δ-(trimethylsilyloxy)imines
作者:Wim Aelterman、Nicola Giubellina、Elena Stanoeva、Koen De Geyter、Norbert De Kimpe
DOI:10.1016/j.tetlet.2003.09.232
日期:2004.1
Treatment of alpha-chloro-delta-(trimethylsilyloxy)ketimines, obtained by regiospecific alkylation of alpha-chloroketimines with 3-bromo- 1-(trimethylsilyloxy)pro pane, with bases and nucleophiles leads to a variety of oxygen-containing heterocycles, including tetrahydrofurans and tetrahydropyrans. (C) 2003 Elsevier Ltd. All rights reserved.